Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gargling agents to reduce intraoral viral load in COVID-19
NCT04341688Unknown
- Sponsor
- Aga Khan University
- Start
- Dec 2021
- Primary completion
- Jun 2022
- Modality
- Small Molecules, Device-based Delivery
01
Overview
Randomised, triple-blind trial of povidone-iodine, ActiveOxy, neem extract and hypertonic saline in coronavirus disease 2019 (COVID-19), sponsored by Aga Khan University. Status: unknown.
02
Drugs
povidone-iodineActiveOxyneem extracthypertonic saline
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04341688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04341688.